Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Estimating the global prevalence of hepatitis B

The substantial global burden of hepatitis B virus (HBV) infection is increasingly recognised. Recent estimates suggest that HBV infection caused 686 000 deaths in 2013,1 placing HBV in the top 20 causes of human mortality. Despite this, comprehensive reviews of data regarding the burden of chronic HBV at regional and national levels have been scarce. This is an area of particular importance in view of the global diversity in chronic HBV prevalence, and the disproportionate burden experienced by people living in low-resource settings.